Rouanet, Jacques, et al. “Real-Life Use of Bexarotene for T-Cell Cutaneous Lymphoma Management: Efficacy and Tolerance With Low Doses”. Acta Dermato-Venereologica, vol. 102, July 2022, p. adv00746, doi:10.2340/actadv.v102.718.